(Date:5/12/2008)...ces of Pay-for-Performance Programs , At a time ...g, this study finds that while such programs may s...ng physician income, they also change the nature o...rses work together. In-depth interviews with 41 fa...ingdom three years after implementation of a new p...
(Date:5/11/2008)...y 11 /PRNewswire/ -- The Myanmar Relief Fund,( htt...private American and,Myanmar citizens that have th...ms bypassing bureaucratic barriers. Teams of docto...ies are being distributed., The Myanmar Relief Fu...citizens with headquarters in California and Yango...
(Date:5/11/2008)...Biotechnology and Biological Sciences Research Cou...o investigate important aspects of human ageing. ...niversity, Dr Lynne Cox and Dr Robert Saunders hav...s can now be used to study the effects ageing has ...l Aging Cell, the researchers demonstrate the valu...
(Date:5/11/2008)... 20). Senior White House Correspondent Richard,Wol... at the presidential,candidate,s leadership and ma...or the coming mud war with John McCain and the Rep...ll be about the big issues because there,are stark...e economy.,They,re also ready for attacks from ano...
Breaking Medicine News(10 mins):Health News:May/June 2008 Annals of Family Medicine tip sheet 2Health News:May/June 2008 Annals of Family Medicine tip sheet 3Health News:May/June 2008 Annals of Family Medicine tip sheet 4Health News:May/June 2008 Annals of Family Medicine tip sheet 5Health News:May/June 2008 Annals of Family Medicine tip sheet 6Health News:Human aging gene found in flies 2Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 2Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 3Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 4Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 5(Date:5/9/2008)...y Shows Positive Results with X-ray ...Newswire/ -- Roche today announced one-year,result... ACTEMRA(TM),(tocilizumab) can significantly inhib...atients with rheumatoid arthritis (RA), a critical...study also demonstrated that ACTEMRA,reduces disea...
(Date:5/8/2008)...rovement in ADHD symptoms in adults, WASHINGTON, ...P,Nasdaq: SHPGY), the global specialty biopharmac...phase III pivotal study in which VYVANSE,demonstra...Hyperactivity,Disorder (ADHD) symptoms in adults a...s with ADHD often find it challenging to focus and...
(Date:5/8/2008)...e-FirstCall/ -- VION PHARMACEUTICALS,INC. (Nasdaq...ator-sponsored,Phase I/II clinical trial of its le...combination with cytarabine in elderly patients wi... (AML) and high-risk,myelodysplastic syndromes (MD...on of Ellen K. Ritchie, M.D. at The Weill-Cornell ...
(Date:5/8/2008)...tion for Clinicians Concerned About ..., Fla., May 8 /- Alpharma I...maceutical company, announced today that two,studi...Society annual,meeting demonstrate the efficacy, t...f Alpharma Pharmaceuticals, FLECTOR(R) Patch (dicl...
Breaking Medicine Technology:New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 2Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 4Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 5Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 6Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 7Chindex International Inc Announces Transfer to NASDAQ Global Market 8764 1Chindex International Inc Announces Transfer to NASDAQ Global Market 8764 2Chindex International Inc Announces Transfer to NASDAQ Global Market 8764 3Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 1Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 2Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 3VA Hospital Draws Curtain on Innovation That Could Help Reduce Spiraling Cost of Hospital Maintenance Nationwide 8760 1VA Hospital Draws Curtain on Innovation That Could Help Reduce Spiraling Cost of Hospital Maintenance Nationwide 8760 2Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 1Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 2Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 3...la. and NUTLEY, N.J., April 12, 2007,/PRNewswire-F...l,registration clinical trial program ever underta... safety information on the,investigational anemia ...mia associated with chronic kidney disease (CKD) i...data analyses were,presented at the National Kidne...
...Combination Data Highlight Favorable Tolerability ...N, Pa., April 13, 2007 /PRNewswire-FirstCall/ -- V...data from a Phase 1b study,of HCV- 796, a unique, ...hibitor at the 42nd Annual Meeting of the European...is meeting is,being held in Barcelona, Spain. Thes...
Other Medicine Technology:Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 2Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 3Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 4ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 2ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 3ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 4ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 5ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 6The Labcyte Echo 550 compound reformatter performs direct microplate-to-microplate transfers of droplets down to 5 nL using a new "touchless" transfer technology based on focused acoustic energy. Mon
Wellpro 384, compatible with hood installations. An automated liquid handling system for 384-well plates, that quickly and accurately prepares large quantities of serial dilutions. The Wellpro also
Precise, nanoliter-volume liquid handling capability allows you to accurately dispense volumes as small as 5 nanoliters. Precision robotics and flexible software ensure accurate, repeatable X/Y motio
... series of robotic workstations is designed for la...e ideal automation platform for routine sample pre...procedures, improving throughput, process consiste...rep software allows you to control the robotic and...
Medicine Products: